Mark Taylor

5.6k total citations
107 papers, 3.1k citations indexed

About

Mark Taylor is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Taylor has authored 107 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 34 papers in Oncology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Taylor's work include Pancreatic and Hepatic Oncology Research (23 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers) and Gallbladder and Bile Duct Disorders (11 papers). Mark Taylor is often cited by papers focused on Pancreatic and Hepatic Oncology Research (23 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers) and Gallbladder and Bile Duct Disorders (11 papers). Mark Taylor collaborates with scholars based in United Kingdom, United States and Canada. Mark Taylor's co-authors include David J. Etherington, Lloyd McKie, Tom Diamond, B. Dasari, G. Kirk, Kurinchi Selvan Gurusamy, David Martín, Chuan Jin Tan, Ruth M. Starzyk and A. P. McHale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mark Taylor

105 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Taylor United Kingdom 29 1.0k 798 742 670 575 107 3.1k
Marc Aprahamian France 30 539 0.5× 554 0.7× 381 0.5× 783 1.2× 303 0.5× 102 2.7k
Ya‐Jen Chang Taiwan 30 1.2k 1.2× 344 0.4× 372 0.5× 881 1.3× 266 0.5× 84 4.3k
Marc Grégoire France 33 199 0.2× 745 0.9× 749 1.0× 1.2k 1.8× 334 0.6× 109 3.5k
John M. Weiler United States 42 749 0.7× 190 0.2× 1.6k 2.2× 1.3k 1.9× 314 0.5× 131 6.2k
Su Jin Lee South Korea 40 875 0.9× 1.7k 2.2× 1.4k 1.9× 1.7k 2.6× 385 0.7× 272 6.2k
Kim Deswarte Belgium 28 450 0.4× 405 0.5× 634 0.9× 1.2k 1.7× 290 0.5× 53 4.9k
Manabu Kinoshita Japan 37 683 0.7× 378 0.5× 466 0.6× 717 1.1× 555 1.0× 168 4.1k
Kiminori Nakamura Japan 31 701 0.7× 668 0.8× 192 0.3× 1.9k 2.8× 173 0.3× 93 4.0k
Chih‐Ching Wu Taiwan 39 642 0.6× 795 1.0× 600 0.8× 2.1k 3.1× 404 0.7× 152 4.5k
Andrea Vecchi Italy 20 607 0.6× 877 1.1× 431 0.6× 1.5k 2.2× 427 0.7× 71 6.3k

Countries citing papers authored by Mark Taylor

Since Specialization
Citations

This map shows the geographic impact of Mark Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Taylor more than expected).

Fields of papers citing papers by Mark Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Taylor. The network helps show where Mark Taylor may publish in the future.

Co-authorship network of co-authors of Mark Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Taylor. A scholar is included among the top collaborators of Mark Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Taylor. Mark Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nelson, Lonnie A., Susan E. Collins, Emily Taylor, et al.. (2025). Content analysis of perceptions of combined pharmacobehavioral treatment for American Indian people with opioid use disorder.. Psychology of Addictive Behaviors. 39(1). 1–13.
2.
Nesbitt, Heather, Keiran Logan, Keith Thomas, et al.. (2021). Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. Cancer Letters. 517. 88–95. 41 indexed citations
3.
Nesbitt, Heather, Keiran Logan, B.C. White, et al.. (2020). An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer. European Journal of Pharmaceutics and Biopharmaceutics. 157. 233–240. 28 indexed citations
4.
Tarhini, Ahmad A., Sandra J. Lee, Xiaoxue Li, et al.. (2018). E3611—A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma. Clinical Cancer Research. 25(2). 524–532. 6 indexed citations
5.
Edwards, Mark, et al.. (2017). Punishment Attacks in Post-Ceasefire Northern Ireland: An Emergency Department Perspective.. PubMed. 86(2). 90–93. 1 indexed citations
6.
Sheng, Yingjie, Heather Nesbitt, John F. Callan, et al.. (2017). Oxygen generating nanoparticles for improved photodynamic therapy of hypoxic tumours. Journal of Controlled Release. 264. 333–340. 98 indexed citations
7.
Halloran, Christopher, Derek O’Reilly, Dhanny Gomez, et al.. (2016). PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial. Trials. 17(1). 30–30. 24 indexed citations
8.
Taylor, Mark, et al.. (2015). A common autoimmune disease with rare organ involvement. British Journal of Hospital Medicine. 76(6). 367–367. 1 indexed citations
9.
Taylor, Mark. (2015). An SOS on Cybersecurity To protect patient data, hospitals beef up risk management programs. Hello, chief security officers and 'white hat hackers'.. PubMed. 89(2). 36–38. 1 indexed citations
10.
Jones, Claire, Stephen A. Badger, Mike Stevenson, et al.. (2014). PET-CT as a predictor of outcome in resectable colorectal liver metastases. European Journal of Gastroenterology & Hepatology. 26(4). 466–472. 5 indexed citations
11.
Badger, Stephen A., et al.. (2013). Modulation of the Hepatic Cytokine Response to Portal Endotoxaemia using the Probiotic Lactobacillus Plantarum 299v. Journal of Gastroenterology and Hepatology Research. 2(6). 632–637. 2 indexed citations
12.
Jones, Claire, et al.. (2012). The role of cetuximab as first‐line treatment of colorectal liver metastases. HPB. 15(1). 11–17. 11 indexed citations
13.
Stinchcombe, Thomas E., Amy H. Peterman, Carrie B. Lee, et al.. (2011). A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(9). 1569–1577. 30 indexed citations
14.
Clark, E. J., Saxon Connor, Mark Taylor, et al.. (2007). Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma. HPB. 9(6). 472–477. 22 indexed citations
15.
Clark, E. J., Saxon Connor, Mark Taylor, et al.. (2007). Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB. 9(6). 456–460. 121 indexed citations
16.
Vergis, Ashley, et al.. (2007). Structured assessment format for evaluating operative reports in general surgery. The American Journal of Surgery. 195(1). 24–29. 29 indexed citations
17.
McKay, Andrew, et al.. (2006). A cost-utility analysis of treatments for malignant liver tumours: a pilot project. HPB. 9(1). 42–51. 8 indexed citations
18.
Stinchcombe, Thomas E., Petra Bůžková, J. K. Choksi, et al.. (2006). A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer. Lung Cancer. 52(3). 305–311. 8 indexed citations
19.
Groves, Matthew R., et al.. (1996). The prosequence of procaricain forms an α-helical domain that prevents access to the substrate-binding cleft. Structure. 4(10). 1193–1203. 94 indexed citations
20.
Taylor, Mark, Ian F. Connerton, Nicola Cummings, et al.. (1994). An unequivocal example of cysteine proteinase activity affected by multiple electrostatic interactions. Protein Engineering Design and Selection. 7(10). 1267–1276. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Aprahamian Breakdown of academic impact, for papers by Ya‐Jen Chang Breakdown of academic impact, for papers by Marc Grégoire Breakdown of academic impact, for papers by John M. Weiler Breakdown of academic impact, for papers by Su Jin Lee Breakdown of academic impact, for papers by Kim Deswarte Breakdown of academic impact, for papers by Manabu Kinoshita Breakdown of academic impact, for papers by Kiminori Nakamura Breakdown of academic impact, for papers by Chih‐Ching Wu Breakdown of academic impact, for papers by Andrea Vecchi
Rankless by CCL
2026